Pasireotide for postoperative pancreatic fistula

Area of Science:

• Gastroenterology
• Surgical Oncology
• Pharmacology

Background:

• Postoperative pancreatic fistula (POPF) is a significant cause of morbidity and mortality after pancreatic resection.
• Pasireotide, a somatostatin analogue, reduces pancreatic exocrine secretions and may help prevent POPF.
• Current treatments aim to mitigate the high complication rates associated with pancreatic surgery.

Purpose of the Study:

• To evaluate the efficacy of perioperative subcutaneous pasireotide in preventing clinically significant postoperative pancreatic fistula, leak, or abscess.
• To compare the incidence of severe POPF between patients receiving pasireotide and those receiving a placebo.
• To assess the impact of pasireotide across different surgical procedures and pancreatic duct conditions.

Main Methods:

• A single-center, randomized, double-blind trial involving 300 patients undergoing pancreaticoduodenectomy or distal pancreatectomy.
• Patients received either 900 μg of subcutaneous pasireotide or placebo twice daily for 7 days, starting preoperatively.
• Randomization was stratified by resection type and pancreatic duct dilation; the primary endpoint was grade 3 or higher POPF, leak, or abscess.

Main Results:

• The primary endpoint occurred in 15% of all patients (45/300).
• Pasireotide significantly reduced the rate of grade 3 or higher POPF, leak, or abscess compared to placebo (9% vs. 21%; relative risk, 0.44; P=0.006).
• This benefit was consistent across pancreaticoduodenectomy and distal pancreatectomy subgroups, and in patients with both dilated and nondilated pancreatic ducts.

Conclusions:

• Perioperative pasireotide treatment effectively decreased the rate of clinically significant postoperative pancreatic fistula, leak, or abscess.
• Pasireotide represents a potential therapeutic option for reducing complications following pancreatic resection.
• The study provides evidence for the use of pasireotide in enhancing surgical outcomes in pancreatic procedures.